Cytox

Pre Diagnostics

This company develops intracellular blood tests and biomarker analytical services for the early detection of Alzheimer's disease for patients, practitioners and researchers.

ADmit Therapeutics

ADmit Therapeutics develops blood-based epigenetic tests for early Alzheimer's disease detection to assist pharmaceutical companies and healthcare providers with clinical trials and patient care.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

CFDX

CFDX develops artificial intelligence technology to detect dementia earlier than traditional methods for healthcare providers and clinical research organisations.

Alzeca Biosciences

This company develops MRI contrast agents to enable early diagnosis of Alzheimer's disease and other neurodegenerative disorders for healthcare providers and clinical researchers.

3X Genetics

This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.

Promental Health

Promental Health develops a blood test using microRNA biomarkers and machine learning for the early diagnosis of Alzheimer's disease for healthcare providers.

CytoTerra

This company develops next-generation sequencing assays to detect chromosomal abnormalities for clinical researchers and healthcare providers specialising in oncology and genetic diseases.